About Us

Hai Kang Life Corporation Limited (HKLife) is a pioneering biotechnology company with global presence, serving to advance molecular technology, and development of biotechnology applications and systems into innovative products that significantly enhance clinical diagnostics and monitoring of quality and safety for the veterinary and food markets worldwide.
Founded in 1999, Hai Kang Life Corporation Limited was established as a biotechnology company and set out to commercialize research undertaken on the molecular diagnostics of infectious diseases. Formerly named Hong Kong DNA Chips Limited (HKDNA), the company launched its first innovative biotechnology product, a H5 Avian Influenza Virus Detection Kit, which went on to receive international recognition for utilizing advanced molecular biological techniques to provide immediate and sensitive detection of the genetic virus that was and continues to present a threat worldwide.
Throughout the last decade, HKLife has made a significant commitment to research and development in advancing molecular diagnostics to functional reality, producing innovative lines of clinical and non-clinical diagnostic products, and delivering practical solutions to ensure the health and safety of society. In 2000, HKLife established Hong Kong's first fully-dedicated commercial molecular testing and R&D laboratory, offering testing services to the world’s research and industrial markets. We are strategically positioned at the hub of Asian biotechnology with our research and testing laboratories located in Hong Kong and Beijing China; offering microbiological and chemical services, and advanced technologies in nucleic acid based testing, utilizing PCR (polymerase chain reaction) and NASBA (Nucleic Acid Sequence-Based Amplification) platform technologies.
At HKLife, we hold ourselves to the highest standards of excellence and accuracy in the testing industry. We have received international recognition from various quality assurance systems. Recognized as one of the world’s leading GM (genetically modified) food testing laboratories in Asia, HKLife was the first commercial laboratory in Hong Kong to receive ISO (International Organization for Standardization) accreditation in this service. Please see our certificates and scope of accreditations.
HKLife's cornerstone reputation in testing and certification also stems from the company's quick and accurate response to the early years' outbreaks of infectious diseases including avian influenza (AI), foot-and-mouth disease (FMD), Severe Acute Respiratory Syndrome (SARS), We have established relationships with government health and agriculture agencies in various countries throughout the South Pacific region,the Middle East and Europe; this enables us to maneuver quickly to assist during emergencies, monitor the climate of the biotechnology industry and keep abreast of changing rules, regulations, needs and trends.


Our Mission

To revolutionize the practice of clinical diagnostics, providing effective platforms for point-of-care applications focused on personalized medicine and pre-emptive surveillance of emerging pathogens and diseases.

Our Vision

Our vision is to be the world’s leading molecular diagnostics company. We are developing advanced and exciting new products utilizing DNA-based technologies and leveraging a unique business model that drives our vision. Incorporated into the vision is the development of our novel EFADchip® technology into a fully-functional platform that will revolutionize the practice of clinical and point-of-care (POC) diagnostic practices, delivering extreme market potential to local and global biotechnology industries.


Core Team



Professor Albert Cheung-Hoi YU, PhD, JP
(Founder and Chairman)
Chairman, Hong Kong Biotechnology Organization
Chairman, The Hong Kong Council for Testing and Certification
Vice-Director of the Neuroscience Research Institute, Professor of the Department of Neurobiology and a Professor at the Infectious Disease Center at Peking University.

Professor Albert Yu is a world-renowned bio-entrepreneur and scientist with over 20 years of experience in the field. He has published over 170 peer reviewed scientific papers, several commentaries in Science and Nature Biotechnology, 8 books and he is an inventor of numerous technologies, with 65 patents over the world. He is the founder and current chairman of HKLife Corporation Limited, a Hong Kong-based biotechnology company with offices in Hong Kong and Beijing, specialized in the R & D and commercialization of molecular diagnostics.


Professor Yu is the Vice-Director of the Neuroscience Research Institute, Professor of the Department of Neurobiology and Professor at the Infectious Disease Center at Peking University. Professor Yu is also the founder and president of Hong Kong Biotechnology Organization (HKBIO), founder and president of Guangdong-Hong Kong-Macau Great Bay Area Biotechnology Alliance, director of the Asian Fund for Cancer Research and on the Board of Trustees of the Gordon Research Conference. He is a Justice of the Peace and was previously a member of the board of directors of the Hong Kong Science and Technology Park.




(Director of General Management)

Ms. Tina Liu obtained Master of Business and Administration (MBA) in Beihang University. She joined HKLife in 2007, serving as regulatory specialist and administration manager and now is Director of general management, in charge of the finance, administration, human resource and legal affairs. Before joining HKLife, she worked international and foreign owned enterprises such as Beijing Yanjing Brewery and Qiagen. She has strong experience and strength in administration, operation and coordination.



Zhaoyang YE, PhD
(Chief Scientific Officer)

Dr. Zhaoyang Ye has around 20 years’ experience in both academia and industry. He graduated from University of Tennessee with a PhD degree in pharmaceutical science and conducted his postdoctoral training at Johns Hopkins University. His expertise spans materials science & engineering, molecular and cell biology, biotechnology and pharmaceutics. He has published more than 60 scientific papers and is the holder of 4 patents. His work was sponsored by government foundations including National Natural Science Foundation of China. He serves as guest editor and member of the editorial board for many scientific journals, besides being an ad hoc reviewer for several journals and foundations.



Sandy KWOK, PhD
(Assistant Chief Scientific Officer)

Dr. Sandy Kwok is a chemical engineer and graduated from the University of Cambridge, UK with Master’s and PhD degrees in chemical engineering and biotechnology. At HKLife, she is responsible for chip production, process equipment design and product development.





SHI Xiaowei, PhD
(Assistant Chief Scientific Officer)

Dr. Xiaowei Shi is a biologist graduated from the Institute of Botany, Chinese Academy of Sciences with a PhD degree in developmental biology. Currently he is a post-doctoral fellow jointly trained by HKLife and Capital Medical University. At HKLife, he is leading the clinical validation and sample preparation of HKLife’s diagnostic platform.


(Project Manager)

Dr. Bin Yang is a biologist and graduated from China Agricultural University with a PhD degree in biochemistry and molecular biology. Trained and experienced in the biosafety evaluation of genetically modified cloned animals, she joined HKLife in 2009 and over the years took up multiple roles ranging from Researcher to Technical Support and Sales Manager. As Project Manager, she oversees the probe development of HKLife’s platform.


GUO Yufen, MSc
(Project Manager)

Ms. Yufen Guo is a molecular biologist and graduated from China Agricultural University with a Master’s degree in molecular plant pathology. She joined HKLife as a Project Manager in 2011 and is currently responsible for the process development of HKLife’s diagnostic platform.





Jasper Wybe Swierstra, PhD
(Project Manager)

Dr. Jasper Wybe Swierstra graduated from the largest medical center of the Netherlands, the Erasmus Medical Centre, Erasmus University of Rotterdam. Here, he obtained a PhD degree in medical microbiology and infectious disease. He is the recipient of the Academic Year Prize for science communication in 2011 awarded by the Dutch Organization for Scientific Research NWO and author of 4 peer reviewed publications. He has lectured at the University of Applied Sciences in Rotterdam, The Netherlands and as Project Manager, he is responsible for the drug-resistance probe development of HKLife’s diagnostic platform.


Timothy Ho, PhD
(Research Scientist)

Dr. Timothy Ho is a biochemist graduated from Hong Kong University of Science and Technology in Hong Kong with Master’s and PhD degrees in biochemistry, biopsychiatry and phytochemistry. He holds two pending patents, obtained during his PhD training. After his PhD, he continued as a postdoctoral researcher. At HKLife, he is responsible for process validation and stability testing of HKLife’s diagnostic platform.


 LIU Wei, MSc
(Research Manager)

Ms. Wei Liu obtained a Master’s degree of phytomolecular pathology in Chinese Academy of Agricultural Sciences. She has plenty of experience in project management and scientific writing. She joined HKLife in 2014, currently is appointed as research manager. She assists the Chief Scientific Officer in project management and file documentation.


Scientific Advisory Board



Bernard ROIZMAN, ScD
(Discoverer of Herpes Virus)

Member: National Academy of Sciences

Foreign Member: Chinese Academy of Engineering

Professor: University of Chicago




Member: Chinese Academy of Sciences

Professor: Institute of Microbiology Chinese Academy of Sciences




Member: Chinese Academy of Engineering

Professor: National Institute for Viral Disease Control & Prevention  of the Chinese Centre for Disease Control





Jianguo CHEN, PhD

Professor: Peking University

Visiting Professor: University of Tokyo

Yulin DENG, PhD

Professor: Beijing Institute of Technology

Member: International Academy of Aeronautics



Technology Collaborators


© 2018 Hai Kang Life Corporation Limited. All Rights Reserved.